Upload File

evaluating immunotherapy as a new pillar of multimodal head and neck cancer care: where does...

  • Home
  • Health & Medicine
  • Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
99

Upload: pvi-peerview-institute-for-medical-education

Post on 08-Jan-2017

86 views

Category:

Health & Medicine


1 download

Report

TRANSCRIPT

Page 1: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 2: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 3: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 4: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 5: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 6: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 7: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 8: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 9: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 10: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 11: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 12: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 13: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 14: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 15: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 16: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 17: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 18: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 19: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 20: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 21: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 22: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 23: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 24: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 25: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 26: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 27: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 28: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 29: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 30: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 31: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 32: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 33: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 34: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 35: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 36: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 37: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 38: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 39: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 40: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 41: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 42: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 43: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 44: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 45: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 46: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 47: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 48: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 49: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 50: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 51: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 52: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 53: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 54: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 55: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 56: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 57: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 58: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 59: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 60: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 61: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 62: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 63: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 64: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 65: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 66: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 67: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 68: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 69: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 70: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 71: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 72: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 73: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 74: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 75: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 76: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 77: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 78: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 79: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 80: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 81: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 82: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 83: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 84: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 85: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 86: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 87: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 88: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 89: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 90: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 91: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 92: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 93: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 94: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 95: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 96: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 97: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 98: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?
Page 99: Evaluating Immunotherapy as a New Pillar of Multimodal Head and Neck Cancer Care: Where Does Checkpoint Blockade Fit?

Defining Effective Combinations of Immune Checkpoint ... · Cancer Therapy: Preclinical Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy Juan

Immune checkpoint Blockade - Center for Cancer … •The basics of immunotherapy •Mechanism of action of checkpoint blockade •Early clinical experience and the discovery of immune

Combination Approaches with Immune-Checkpoint Blockade in Cancer … · 2017-12-15 · Keywords: cancer immunotherapy, checkpoint blockade, CTLA-4, PD-1 iNTRODUCTiON Historically,

The blockade of immune checkpoints in cancer immunotherapy

Characterization of immunoactive and immunotolerant CD4+ …Oct 08, 2020  · Abstract Cancer immunotolerance can be reversed by checkpoint blockade immunotherapy in some patients,

Heterologous Vaccination and Checkpoint Blockade …...will also be effective in cancers with few nonsynonymous muta-tions, such as B-ALL (5). To determine whether immunotherapy is

Prospects for combining immune checkpoint blockade with PARP … · 2019. 9. 14. · REVIEW Open Access Prospects for combining immune checkpoint blockade with PARP inhibition Anping

Combining Radiation and Immune Checkpoint Blockade in the

Side Effect: Immunotherapy Recognition and Management of ......Adverse Events Associated With Checkpoint Inhibitors are Immune Related Summary of PD-1/PD-L1 Blockade Immune-Mediated

Combination immunotherapy with α-CTLA-4 and α-PD-L1 ......immune checkpoint blockade strategies also appear to enhance clearance of tumors when used in combination with chemotherapy,

Immune checkpoint blockade therapies for HCC: current ......FEASIBILITY OF IMMUNE CHECKPOINT BLOCKADE IN HCC Immune checkpoint blockade therapy can be exploited as an alternative treatment

Intro to Immunotherapy: CAR T Cells, Checkpoint Inhibitors .../media/Non-Clinical/Files-PDFs-Excel...Intro to Immunotherapy: CAR T Cells, Checkpoint Inhibitors, BiTEs, Vaccines, Monoclonal

Combination Immunotherapy Approaches - GBCC Page.pdf · Combination Immunotherapy Approaches Chemotherapy, Radiation Therapy, and Dual Checkpoint Therapy ... • Grant funding from

Immune Checkpoint Blockade: The New Frontier in Cancer … · LEADING ARTICLE Immune Checkpoint Blockade: The New Frontier in Cancer Treatment Jeffrey M. Clarke1 & Daniel J. George2

Immunotherapy in Lung Cancer Treatment: A New Paradigm ......1. To review biology of T cell immune checkpoint blockade 2. To review the new immune checkpoint inhibitors and their roles

Immunomodulatory Monoclonal Antibodies in …...Keywords: monoclonal antibodies, immune checkpoint blockade, combined tumor immunotherapy, clinical trials, cutaneous melanoma iNTRODUCTiON

Checkpoint inhibitors for HBV cure - Virology Educationregist2.virology-education.com/2016/3HBVCure/10_Maini.pdf · Checkpoint inhibitors for HBV cure. ... Checkpoint blockade

Glioblastoma Eradication Following Immune Checkpoint ...cancerimmunolres.aacrjournals.org/content/canimm/4/2/124.full.pdf · Glioblastoma Eradication Following Immune Checkpoint Blockade

Cancer immunotherapy using checkpoint blockade · checkpoint blockade Antoni Ribas1* and Jedd D. Wolchok2,3* The release of negative regulators of immune activation (immune checkpoints)

Immune Checkpoint Blockade in Cancer Therapy …...Jim Allison Immune Checkpoint Blockade in Cancer Therapy Nobel Prize in Physiology or Medicine Lecture 2018 Peptide/MHC TCR CD28

Immune checkpoint blockade and CAR-T cell therapy in … · 2019. 6. 11. · REVIEW Open Access Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies Hao Wang1†,

Combination approaches with immune checkpoint blockade in cancer therapy

CONFERENCE SCHEDULE - American Association for Cancer ...of immune checkpoint blockade in preclinical models. Memorial Sloan Kettering Cancer Center 05:25 p.m. Combination immunotherapy

Head and Neck Cancer Checkpoint Blockade and T Cell

Editorial Checkpoint immunotherapy: good for cancer therapy, … · Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases Leonard Calabrese,1 Vamsidhar Velcheti2

Post-ASCO Immunotherapy Highlights: Checkpoint Inhibition ... · Post-ASCO Immunotherapy Highlights: Checkpoint Inhibition, ... –Presentation will highlight and summarize key clinical

Sensitization to immune checkpoint blockade through ... · the tumor microenvironment . ... dichotomous manner to immune checkpoint blockade (ICB). We compared the cellular composition

Coordinating Immune Checkpoint Blockade For Cancer ...immune-checkpoint.com/wp-content/uploads/sites/24/2014/11/Day-1-1… · Coordinating Immune Checkpoint Blockade For Cancer Immunotherapy

Lenalidomide Enhances Immune Checkpoint Blockade-Induced … · Cancer Therapy: Preclinical Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

Biomarkers for immunotherapy - oncologypro.esmo.org · J. Haanen, NKI-AVL 1. TIL therapy 1. Checkpoint blockade C. Robert, NEJM 2015 Clear value of mobilizing endogenous tumor-specific

Checkpoint Blockade in Cancer Immunotherapy Prof. James ...The screen versions of these slides have full details of copyright and acknowledgements 12 34 MDX-010 (Ipilumumab) Fully

Combined immune checkpoint protein blockade and low dose

Mount Sinai, Hammer Lab & Personalized Alex Rubinsteyn ...Focus: cancer immunotherapy ... Checkpoint blockade Cellular therapies Vaccines Disinhibit CD8+ T-cells, antigens responsible

Combination Approaches with Immune-Checkpoint Blockade in … · Immune-Checkpoint Blockade in Cancer Therapy. Front. Oncol. 6:233. doi: 10.3389/fonc.2016.00233 Combination Approaches

Immunotherapy - download.e-bookshelf.de · Prabhakaran 3 Somatic Mutations and Immunotherapy, 24 Eric Tran 4 Checkpoint Blockade, 37 Tracy A. Proverbs‐Singh, Jedd Wolchok, and Alexandra